Ai Kawamura

Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates

Takuji Kawamura, Shigeru Miyagawa, Satsuki Fukushima et al. · Stem Cell Reports · 2016 · 144 citations · Full text

Life Sciences, Cell Biology, Immunology +11

Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantation

Shohei Yoshida, Shigeru Miyagawa, Toshihiko Toyofuku et al. · Scientific Reports · 2020 · 62 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reports

Takuji Kawamura, Yoshito Ito, Emiko Ito et al. · Frontiers in Cardiovascular Medicine · 2023 · 58 citations · Full text

Medicine, Cardiology, Immunology +16

Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy

Nagako Sougawa, Shigeru Miyagawa, Satsuki Fukushima et al. · Scientific Reports · 2018 · 57 citations · Full text

Medicine, Cardiology, Apoptosis +13

Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application

Emiko Ito, Shigeru Miyagawa, Maki Takeda et al. · Scientific Reports · 2019 · 54 citations · Full text

Life Sciences, Cardiology, Cell Biology +15